Kasugamycin-resistant Mutants of Bacillus Subtilis
Overview
Authors
Affiliations
Kasugamycin-resistant mutants of Bacillus subtilis were isolated and classified into two groups, one of which had resistance to kasugamycin in in vitro protein synthesis and mapped in the ribosomal region. The other group had no resistance to kasugamycin in in vitro protein synthesis and had weak cross-resistance to gentamicin and kanamycin. Neither group could sporulate in the presence of kasugamycin.
A User's Guide to Cell-Free Protein Synthesis.
Gregorio N, Levine M, Oza J Methods Protoc. 2019; 2(1).
PMID: 31164605 PMC: 6481089. DOI: 10.3390/mps2010024.
ksgA mutations confer resistance to kasugamycin in Neisseria gonorrhoeae.
Duffin P, Seifert H Int J Antimicrob Agents. 2008; 33(4):321-7.
PMID: 19097863 PMC: 2723803. DOI: 10.1016/j.ijantimicag.2008.08.030.
Conditional lethal mutants of Bacillus subtilis dependent on kasugamycin for growth.
Pai Y, Dabbs E Mol Gen Genet. 1981; 183(3):478-83.
PMID: 6801425 DOI: 10.1007/BF00268768.
Genetic mapping of a linked cluster of ribosomal ribonucleic acid genes in Bacillus subtilis.
Wilson F, Hoch J, Bott K J Bacteriol. 1981; 148(2):624-8.
PMID: 6795182 PMC: 216248. DOI: 10.1128/jb.148.2.624-628.1981.
TABER H, Dellers E, Lombardo L J Bacteriol. 1981; 145(1):321-7.
PMID: 6780514 PMC: 217275. DOI: 10.1128/jb.145.1.321-327.1981.